
Avita Medical
Avita Medical Inc. is a regenerative medicine company specializing in therapeutic skin restoration. Their flagship product, the RECELL System, is FDA-approved for treating thermal burn wounds and full-thickness skin defects. The company leverages patient-derived skin cells to enhance healing and accelerate recovery, positioning itself as a leader in acute wound care solutions.
Short position
Avita Medical (ASX:AVH) has 0.12% of its shares on issue reported as short positions as of 5 Oct 2026, or about 88,026 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.14 percentage points. Its highest recorded short interest was 10.06% in November 2020. AVH is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Avita Medical (AVH) short interest history
AVH Short Interest History
- 30-day change
- -0.03pp
- 90-day change
- -0.14pp
- 1-year change
- -0.02pp
- All-time high
- 10.06% (November 2020)
- All-time low
- 0.00% (November 2025)
Is AVH heavily shorted?
Not especially: 0.12% short interest is modest by ASX standards, ranking #438 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has AVH's short interest changed recently?
Over the past 30 days Avita Medical's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.12% of shares on issue.
What is the highest AVH's short interest has been?
Since 2014, Avita Medical's short interest peaked at 10.06% in November 2020 and bottomed at 0.00% in November 2025.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2014. See our methodology.